City

Clinical trials near London, United Kingdom

Active studies with a listed research site in London, United Kingdom.

29active studies

18recruiting now

25countries represented

59largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

ObesityCondition

Ribupatide, SemaglutideTreatment

Australia, Bulgaria59 locations

KaileraSponsor

Updated 2026-09-01 · NCT07284979See eligibility →

Recruiting nowNot applicable

Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial

ObesityCondition

Intensive weight loss intervention, Bariatric surgeryTreatment

Denmark, United Kingdom14 locations

Carsten DirksenSponsor

Updated 2026-08-21 · NCT06309238See eligibility →

Recruiting nowNot applicable

Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease

Healthy, Fatty LiverCondition

Bioimpedence Vector AnalysisTreatment

United Kingdom1 locations

Richmond Research InstituteSponsor

Updated 2026-08-19 · NCT04873258See eligibility →

Recruiting nowPhase 4

Fibrosis Lessens After Metabolic Surgery

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver DiseaseCondition

Metabolic surgery, Incretin-Based TherapyTreatment

Brazil, Canada22 locations

The Cleveland ClinicSponsor

Updated 2026-07-31 · NCT06374875See eligibility →

Recruiting nowNot applicable

Periodontal Assessment of a Bariatric Care Population

Bariatric Surgery Candidate, ObesityCondition

Intervention not listedTreatment

United Kingdom4 locations

Queen Mary University of LondonSponsor

Updated 2026-07-02 · NCT04851470See eligibility →

Recruiting nowPhase 3

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

Hypothalamic Obesity, Multiple Pituitary Hormone Deficiency Genetic FormCondition

Setmelanotide, PlaceboTreatment

United Kingdom, United States11 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-02-12 · NCT06760546See eligibility →

Recruiting nowNot applicable

Comorbid Obesity and Depression With an Anti-inflammatory Medication

Obesity, Major Depressive DisorderCondition

Minocycline 200mgTreatment

United Kingdom1 locations

King's College LondonSponsor

Updated 2025-11-14 · NCT06537921See eligibility →

Recruiting nowNot applicable

Effects of a Collagen Supplement on Quality of Life, Appetite and Glycaemic Control

Quality of Life, AppetiteCondition

Collagen peptide supplement, PlaceboTreatment

United Kingdom1 locations

King's College LondonSponsor

Updated 2025-11-14 · NCT07229014See eligibility →

Recruiting nowNot applicable

The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease

Bronchial Asthma, BronchiectasisCondition

Intervention not listedTreatment

United Kingdom1 locations

University College, LondonSponsor

Updated 2025-07-11 · NCT07060079See eligibility →

Recruiting nowNot applicable

The Effect of Exercise in Patients Awaiting Bariatric Surgery

Bariatric Surgery Candidate, ObesityCondition

Online exercise interventionTreatment

United Kingdom1 locations

University College, LondonSponsor

Updated 2025-05-21 · NCT05235945See eligibility →

Recruiting nowNot applicable

The Poor Responders Study

Bariatric Surgery Candidate, Obesity, MorbidCondition

Gut hormonesTreatment

United Kingdom1 locations

Imperial College LondonSponsor

Updated 2025-05-09 · NCT05404061See eligibility →

Recruiting nowNot applicable

Personalized Responses to Dietary Composition Trial 3

Diabetes, Heart DiseasesCondition

Dietary InterventionTreatment

United Kingdom, United States2 locations

Zoe Global LimitedSponsor

Updated 2025-04-16 · NCT04735835See eligibility →

Recruiting nowNot applicable

The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes

Steroid-Induced Diabetes, Steroid Induced HyperglycemiaCondition

Semaglutide Oral Product, Metformin Oral TabletTreatment

United Kingdom1 locations

Imperial College LondonSponsor

Updated 2024-10-02 · NCT06318442See eligibility →

Recruiting nowNot applicable

A UK Registry for Metabolic and Bariatric Endoscopic Interventions

Obesity, Diabetes Mellitus, Type 2Condition

Endoscopic gastric suturing, Endoscopic gastric plicationTreatment

United Kingdom1 locations

Cleveland Clinic LondonSponsor

Updated 2024-03-15 · NCT06305208See eligibility →

Recruiting nowNot applicable

Who Will Benefit From Bariatric Surgery for Diabetes?

Diabetes Mellitus, Type 2, ObesityCondition

Roux-en-Y gastric bypass (RYGB)Treatment

United Kingdom1 locations

Imperial College LondonSponsor

Updated 2023-04-19 · NCT03842475See eligibility →

Recruiting nowNot applicable

Effect of Obesity, Diabetes and Bariatric Surgery on Pregnancy Outcomes

Obesity, Pregnancy in DiabeticCondition

ObservationalTreatment

United Kingdom1 locations

Chelsea and Westminster NHS Foundation TrustSponsor

Updated 2023-03-03 · NCT05753124See eligibility →

Recruiting nowNot applicable

The European NAFLD Registry

NAFLD, NASHCondition

Intervention not listedTreatment

Belgium, Finland37 locations

Newcastle UniversitySponsor

Updated 2023-01-06 · NCT04442334See eligibility →

Recruiting nowNot applicable

Gut Hormones and Roux en Y Gastric Bypass

Obesity, Type 2 DiabetesCondition

Roux en Y Gastric Bypass Surgery, Gut hormone infusionTreatment

United Kingdom1 locations

Imperial College LondonSponsor

Updated 2021-04-20 · NCT01945840See eligibility →

Opening soonNot applicable

3D Reconstruction, VR and Machine Learning in Body Image in Bariatrics

Obesity (Disorder), Body ImageCondition

Body Image Counselling with Virtual RealityTreatment

United Kingdom1 locations

Imperial College LondonSponsor

Updated 2026-06-25 · NCT07668492See eligibility →

Invitation onlyNot applicable

A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

ObesityCondition

SemaglutideTreatment

Spain, Switzerland30 locations

Novo Nordisk A/SSponsor

Updated 2026-08-04 · NCT07055607See eligibility →

Invitation onlyNot applicable

Real-world Exploration of Digital iNnovation in the Management of Excess Weight

Obesity, Obesity & OverweightCondition

Digital Weight Management ProgrammeTreatment

United Kingdom1 locations

Guy's and St Thomas' NHS Foundation TrustSponsor

Updated 2026-04-29 · NCT07283978See eligibility →

Invitation onlyPhase 2

A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

Hypothalamic ObesityCondition

BivamelagonTreatment

United Kingdom, United States9 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-02-10 · NCT07156578See eligibility →

Invitation onlyNot applicable

A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy

Pregnancy, ObesityCondition

No InterventionTreatment

Spain, United Kingdom3 locations

Novo Nordisk A/SSponsor

Updated 2026-01-14 · NCT05872022See eligibility →

Active, not recruitingPhase 3

A Trial of Setmelanotide in Acquired Hypothalamic Obesity

Hypothalamic ObesityCondition

Setmelanotide, PlaceboTreatment

Canada, Germany28 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-08-10 · NCT05774756See eligibility →

Active, not recruitingPhase 3

A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

ObesityCondition

Cagrilintide, SemaglutideTreatment

Belgium, Canada36 locations

Novo Nordisk A/SSponsor

Updated 2026-01-20 · NCT06780449See eligibility →

Active, not recruitingPhase 2

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

Diabetes Mellitus, Type 2, Diabetic Peripheral NeuropathyCondition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

Canada, Denmark54 locations

Novo Nordisk A/SSponsor

Updated 2025-12-05 · NCT06797869See eligibility →

Active, not recruitingNot applicable

Genetic Determinants of Kidney Disease in People of African Ancestry With HIV

HIV Nephropathy, Kidney InjuryCondition

Intervention not listedTreatment

United Kingdom1 locations

King's College Hospital NHS TrustSponsor

Updated 2025-09-03 · NCT05685810See eligibility →

Active, not recruitingPhase 3

Semaglutide 2.4 mg in Patients With Poor Weight-loss

Obesity, DiabetesCondition

Semaglutide 3 mg, PlaceboTreatment

United Kingdom1 locations

University College, LondonSponsor

Updated 2024-12-06 · NCT05073835See eligibility →

Active, not recruitingNot applicable

Adults Regulating Their Weight Everyday With Mobile Internet Support

ObesityCondition

ARTEMIS mobile appTreatment

United Kingdom1 locations

University of OxfordSponsor

Updated 2024-11-20 · NCT05787652See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near London, United Kingdom

Current studies

Related cities